Viewing Study NCT04913220


Ignite Creation Date: 2025-12-25 @ 4:14 AM
Ignite Modification Date: 2026-05-07 @ 6:21 PM
Study NCT ID: NCT04913220
Status: TERMINATED
Last Update Posted: 2025-03-05
First Post: 2021-05-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of SAR444245 Combined With Cemiplimab for the Treatment of Participants With Various Advanced Skin Cancers (Pegathor Skin 201)
Sponsor: Sanofi
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Malignant Melanoma View
None Squamous Cell Carcinoma of Skin View
Keywords: